| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 02/13/1997 | WO1997004796A1 Conjugation-stabilized therapeutic agent compositions, delivery and diagnostic formulations |
| 02/13/1997 | WO1997004795A2 Pharmaceutical compositions containing cyclosporin or other peptide substances |
| 02/13/1997 | WO1997004789A1 Tablets containing anion exchange resin |
| 02/13/1997 | WO1997004787A1 Liposomal oligonucleotide compositions |
| 02/13/1997 | WO1997004784A1 Novel hormonal medicaments and use thereof for correcting oestrogen deficiencies |
| 02/13/1997 | WO1997004782A1 Solid dispersion or solid dispersion preparation of xanthine derivatives |
| 02/13/1997 | WO1997004768A1 Non-ionic surfactant vesicles as therapeutic agent |
| 02/13/1997 | WO1997004764A1 Topical phenylephrine preparation |
| 02/13/1997 | WO1997004759A1 Transdermal patch containing aspirin |
| 02/13/1997 | WO1997004758A1 Pharmaceutical preparation for percutaneous absorbtion |
| 02/13/1997 | WO1997004757A1 Transdermal nitrate formulation |
| 02/13/1997 | WO1997004756A2 Methacrylate backbone surfactants in nanoparticulate formulations |
| 02/13/1997 | WO1997004755A1 Hard gelatin capsules with low water transport and process for the production thereof |
| 02/13/1997 | WO1997004754A1 Chewing tablets with an effervescent action |
| 02/13/1997 | WO1997004753A1 Pharmaceutical compositions of conjugated estrogens and methods for their use |
| 02/13/1997 | WO1997004752A1 Pharmaceutical compositions of conjugated estrogens and methods for their use |
| 02/13/1997 | WO1997004751A1 Co-processing method for making a free-flowing compressible powder and tablet therefrom |
| 02/13/1997 | WO1997004750A2 Process for preparing solid dosage forms of very low-dose drugs |
| 02/13/1997 | WO1997004749A1 Method for preparing dry pharmaceutical forms, and resulting pharmaceutical compositions |
| 02/13/1997 | WO1997004748A2 Enhanced artificial viral envelopes for cellular delivery of therapeutic substances |
| 02/13/1997 | WO1997004747A1 Drug delivery systems for macromolecular drugs |
| 02/13/1997 | WO1997004746A1 Methods of making liposomes containing hydro-monobenzoporphyrin photosensitizers |
| 02/13/1997 | WO1997004745A2 Ophthalmological composition for protecting the eyes from irritation caused by ozone and/or uv radiation |
| 02/13/1997 | WO1997004744A1 Polymeric drug formulations |
| 02/13/1997 | WO1997004742A1 Oral compositions |
| 02/13/1997 | WO1997004741A1 Preparation used in dental care |
| 02/13/1997 | WO1997004728A1 Apparatus and methods for improved noninvasive dermal administration of pharmaceuticals |
| 02/13/1997 | WO1997004668A2 Two-stage preparation |
| 02/13/1997 | WO1997002003A3 Compositions |
| 02/13/1997 | WO1997001324A3 Cosmetic and/or pharmaceutical preparations |
| 02/13/1997 | WO1997000671A3 Composition for preparing finely dispersed systems and process for preparing the same |
| 02/13/1997 | WO1996041646A3 Pharmaceutical compositions containing lornoxicam and cyclodextrin |
| 02/13/1997 | WO1996040627A3 Thiocationic lipids, pharmaceutical compositions and methods of use thereof |
| 02/13/1997 | WO1996040086A3 Compositions and methods for topical administration of pharmaceutically active agents |
| 02/13/1997 | WO1996040058A3 Liquid fluorocarbon emulsion as a vascular nitric oxide reservoir |
| 02/13/1997 | WO1996002239A3 Enhanced loading of solutes into polymer gels and methods of use |
| 02/13/1997 | DE19529348A1 Absorptionsmittel für Wasser und wässrige Flüssigkeiten sowie Verfahren zu ihrer Herstellung und Verwendung Absorbents for water and aqueous liquids, as well as processes for their preparation and use |
| 02/13/1997 | CA2745743A1 Stabile isotonic lyophilized protein formulation |
| 02/13/1997 | CA2228298A1 Non-ionic surfactant vesicles as therapeutic agent |
| 02/13/1997 | CA2228118A1 Multiblock biodegradable hydrogels for use as controlled release agents for drugs delivery and tissue treatments agents |
| 02/13/1997 | CA2228048A1 Process for preparing solid dosage forms of very low-dose drugs |
| 02/13/1997 | CA2228034A1 Transdermal patch containing aspirin |
| 02/13/1997 | CA2227989A1 Liposomal oligonucleotide compositions |
| 02/13/1997 | CA2226892A1 Method of detecting lung disease |
| 02/13/1997 | CA2226624A1 Methods for treatment of allergic asthma |
| 02/13/1997 | CA2201144A1 Method for making granules, and resulting granules |
| 02/13/1997 | CA2200984A1 Enhanced transdermal transfer using ultrasound |
| 02/12/1997 | EP0757911A1 New galenic formulations containing fenofibrate and their applications |
| 02/12/1997 | EP0757910A1 Percutaneously administrable base composition and percutaneously administrable drug composition prepared therefrom |
| 02/12/1997 | EP0757718A1 Methods of use of uncoated gel particles |
| 02/12/1997 | EP0757554A1 Lollipop with tooth plaque neutralising effect |
| 02/12/1997 | CN1142833A Poly-beta-1-4-N-acetylglucosamine |
| 02/12/1997 | CN1142772A Parathyroid hormone formulation |
| 02/12/1997 | CN1142766A Combined antipyretic analgesic drug |
| 02/12/1997 | CN1142764A Sucrose ester C-zo to C-28 alcohol formulations |
| 02/12/1997 | CN1142763A Controlled-release pharmaceutical preparation |
| 02/12/1997 | CN1142762A Optionally crosslinkable coatings, compositions and methods of use |
| 02/12/1997 | CN1142748A Coprocessed galactomannan-glucomannan |
| 02/12/1997 | CN1142394A Oral liquid of purslane speedwell and preparation thereof |
| 02/12/1997 | CN1142393A Preparation and usage of reducing viscosity Chinese medicine capsule |
| 02/12/1997 | CN1142387A Chinese medicine paste "Pifubadugao' for dermatosis |
| 02/12/1997 | CN1142385A Medical composition for curing infertility and preparation thereof |
| 02/12/1997 | CN1142384A Preparation of medicine for hepatic diseases |
| 02/12/1997 | CN1142379A Capsule of ginkgo leaves |
| 02/12/1997 | CN1142372A Pellets for curing diarrhea |
| 02/12/1997 | CN1142371A Pellet for curing diarrhea |
| 02/12/1997 | CN1142365A Iodine oral liquid and preparation thereof |
| 02/12/1997 | CN1142359A Pellets of nifedipine |
| 02/12/1997 | CN1142358A Pellets of captopril |
| 02/12/1997 | CN1142357A Solid drink effervescive pellets and preparation thereof |
| 02/12/1997 | CN1033997C Method for prepn. of pigeon milk nutritious |
| 02/12/1997 | CA2183020A1 Activated immunoglobulin |
| 02/11/1997 | US5602183 Diaper dermatitis; mixture of antiinflammatory agent andpyruvate compound, antioxidant and fatty acids |
| 02/11/1997 | US5602182 Containing a combination of polyethylene glycol and sodium carboxymethylcellulose |
| 02/11/1997 | US5602180 Method of administering EDTA complexes |
| 02/11/1997 | US5602165 Transdermal absorptive drug formulation |
| 02/11/1997 | US5602148 Polyethylene glycol as a solubilizer |
| 02/11/1997 | US5602116 Administering vitamin d analog |
| 02/11/1997 | US5602107 Applying topically for treatment of ecto- and endoparasites |
| 02/11/1997 | US5601846 Oligopeptide |
| 02/11/1997 | US5601845 Cores containing diltiazem(or salt) and microcrystalline cellulose coated with ethyl cellulose, for controlled release oral drug delivery |
| 02/11/1997 | US5601844 Sustained release medicinal preparation |
| 02/11/1997 | US5601843 Core of non-steroidal anti-inflammatory agent surrounded by mantle of a prostaglandin; stability |
| 02/11/1997 | US5601842 Analgesics; contains a non-moisture sensitive matrixing agent |
| 02/11/1997 | US5601839 Triacetin as a penetration enhancer for transdermal delivery of a basic drug |
| 02/11/1997 | US5601838 Method for treating pain associated with herpes-zoster and post-herpetic neuralgia |
| 02/11/1997 | US5601835 Insertion into central nervous system |
| 02/11/1997 | US5601799 Glycoprotein has affinity to macrophages, useage as drug delivery |
| 02/11/1997 | US5601076 Spheroidal polycrystallite having continuous three-dimensional structure comprising small crystallites arranged around spheroidal center |
| 02/11/1997 | CA2048924C Teat treating compositions, production and use |
| 02/11/1997 | CA2022640C Rotogranulations and taste masking coatings for preparation of chewable pharmaceutical tablets |
| 02/06/1997 | WO1997003939A1 Novel amide-based cationic lipids |
| 02/06/1997 | WO1997003718A1 Transcorneal drug-release system |
| 02/06/1997 | WO1997003710A1 Wound treatment composition |
| 02/06/1997 | WO1997003709A1 Agent, for transdermal application, containing esters of 3-ketodesogestrel |
| 02/06/1997 | WO1997003703A1 Adeno-associated viral liposomes and their use in transfecting dendritic cells to stimulate specific immunity |
| 02/06/1997 | WO1997003702A1 A method for gene therapy using nucleic acid loaded polymeric microparticles |
| 02/06/1997 | WO1997003701A2 Compounds and methods for treatment of egf receptor associated cancers and purification of the egf receptor |
| 02/06/1997 | WO1997003699A1 Use of hyaluronic acid and a nsaid for the manufacture of a medicament for the treatment of mucosal diseases |
| 02/06/1997 | WO1997003698A1 Hormone patch |